This company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsMedMen Enterprises（MMNF.Q）株式概要MedMen Enterprises Inc.は、その子会社とともに米国で大麻小売業を営んでいる。 詳細MMNF.Q ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長0/6過去の実績0/6財務の健全性0/6配当金0/6リスク分析最新の財務報告は1年以上前のものである 意味のある時価総額がありません ( $2K )すべてのリスクチェックを見るMMNF.Q Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueUS$Current PriceUS$0.000001100.0% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-220m161m2016201920222025202620282031Revenue US$120.1mEarnings US$17.6mAdvancedSet Fair ValueView all narrativesMedMen Enterprises Inc. 競合他社AmeriCannSymbol: OTCPK:ACANMarket cap: US$4.9kFilament HealthSymbol: OTCPK:FLHL.FMarket cap: US$26.2kPetros PharmaceuticalsSymbol: OTCPK:PTPIMarket cap: US$269.4kEcofibreSymbol: OTCPK:EOFB.FMarket cap: US$366.6k価格と性能株価の高値、安値、推移の概要MedMen Enterprises過去の株価現在の株価US$0.00000152週高値US$0.0152週安値US$0.000001ベータ01ヶ月の変化0%3ヶ月変化0%1年変化0%3年間の変化-99.90%5年間の変化-99.90%IPOからの変化-99.90%最新ニュースお知らせ • Apr 28+ 1 more updateMedMen Enterprises Inc. Announces Resignation of DirectorsMedMen Enterprises Inc. announced that it made an assignment into bankruptcy pursuant to Canadas Bankruptcy and Insolvency Act (the Bankruptcy Proceedings) on April 24, 2024 and B. Riley Farber Inc. was appointed as the Company's bankruptcy trustee (in such capacity, the Bankruptcy Trustee). The each of the Company's directors resigned effective immediately prior to the commencement of the Bankruptcy Proceedings.お知らせ • Jan 25+ 1 more updateMedMen Enterprises Inc. Announces Management ChangesMedMen Enterprises Inc. announced that Ellen Deutsch Harrison has stepped down as board member effective January 19, 2024 and the board has appointed Richard Ormond as chief restructuring officer. Furthermore, Michael Serruya, executive chairman of the board, who has served on the Board since August 2021, has stepped down from the Board effective January 24, 2024.お知らせ • Nov 18MedMen Enterprises Inc. announced delayed 10-Q filingOn 11/17/2023, MedMen Enterprises Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jul 06+ 2 more updatesMedMen Enterprises Inc. Appoints Ellen Deutsch to Board of DirectorsMedMen Enterprises Inc. announced the appointment of Ellen Deutsch to the Company’s Board of Directors, increasing the size of the Board of Directors to six. Deutsch brings deep operational, marketing, and financial experience and expertise in the cannabis and CPG industries, having most recently served as Senior Vice President of Market Development and Shared Services at Acreage Holdings. Before joining Acreage, Deutsch served as Executive Vice President/Chief Operating Officer at Stem Holdings, Inc, following two decades in the C-suite of Hain Celestial as its Senior Vice President/Chief Growth Officer among other leadership roles.お知らせ • Jun 17MedMen Enterprises Inc. Announces CFO Changes, Effective June 29, 2023MedMen Enterprises Inc. announced the resignation of Ana Bowman as Chief Financial Officer, effective June 29, 2023. Bowman has served as CFO since 2022. MedMen has begun a formal search for a new CFO.お知らせ • May 06MedMen Enterprises Inc. announced delayed 10-Q filingOn 05/05/2023, MedMen Enterprises Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.最新情報をもっと見るRecent updatesお知らせ • Apr 28+ 1 more updateMedMen Enterprises Inc. Announces Resignation of DirectorsMedMen Enterprises Inc. announced that it made an assignment into bankruptcy pursuant to Canadas Bankruptcy and Insolvency Act (the Bankruptcy Proceedings) on April 24, 2024 and B. Riley Farber Inc. was appointed as the Company's bankruptcy trustee (in such capacity, the Bankruptcy Trustee). The each of the Company's directors resigned effective immediately prior to the commencement of the Bankruptcy Proceedings.お知らせ • Jan 25+ 1 more updateMedMen Enterprises Inc. Announces Management ChangesMedMen Enterprises Inc. announced that Ellen Deutsch Harrison has stepped down as board member effective January 19, 2024 and the board has appointed Richard Ormond as chief restructuring officer. Furthermore, Michael Serruya, executive chairman of the board, who has served on the Board since August 2021, has stepped down from the Board effective January 24, 2024.お知らせ • Nov 18MedMen Enterprises Inc. announced delayed 10-Q filingOn 11/17/2023, MedMen Enterprises Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jul 06+ 2 more updatesMedMen Enterprises Inc. Appoints Ellen Deutsch to Board of DirectorsMedMen Enterprises Inc. announced the appointment of Ellen Deutsch to the Company’s Board of Directors, increasing the size of the Board of Directors to six. Deutsch brings deep operational, marketing, and financial experience and expertise in the cannabis and CPG industries, having most recently served as Senior Vice President of Market Development and Shared Services at Acreage Holdings. Before joining Acreage, Deutsch served as Executive Vice President/Chief Operating Officer at Stem Holdings, Inc, following two decades in the C-suite of Hain Celestial as its Senior Vice President/Chief Growth Officer among other leadership roles.お知らせ • Jun 17MedMen Enterprises Inc. Announces CFO Changes, Effective June 29, 2023MedMen Enterprises Inc. announced the resignation of Ana Bowman as Chief Financial Officer, effective June 29, 2023. Bowman has served as CFO since 2022. MedMen has begun a formal search for a new CFO.お知らせ • May 06MedMen Enterprises Inc. announced delayed 10-Q filingOn 05/05/2023, MedMen Enterprises Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Nov 24Medmen Enterprises Inc. Prevails in Lawsuit Against Former CFO James ParkerMedMen Enterprises Inc. announced the company has prevailed in a high-profile lawsuit brought by former CFO James Parker. In 2019, Parker filed suit against MedMen, alleging wrongful termination, breach of contract and retaliation, seeking in excess of $20,000,000.00 in damages. MedMen has always maintained that the lawsuit and claims were baseless and without merit. The jury agreed, ruling in favor of MedMen on all claims and determining MedMen does not owe Parker any damages. MedMen also asserted affirmative claims against Parker. The jury found that Parker breached his contract, his fiduciary duty, his duty of loyalty, misappropriated trade secrets, and committed conversion, but that there was no harm/damage resulting from his misconduct.お知らせ • Aug 19MedMen Enterprises Inc. announced that it expects to receive $100 million in funding from Serruya Private Equity Inc.MedMen Enterprises Inc. announced a private placement of 416,666,667 units at a price of $0.24 per unit for gross proceeds of $100,000,000 on August 17, 2021. Each unit will consist of one class B subordinated voting share and one quarter of one share purchase warrant. Each warrant will entitle the holder to purchase a common share at a price of $0.288 per share for a period of five years. The transaction will be led by Serruya Private Equity Inc and included participation from other investors. Pursuant to the transaction, Michael Serruya from Serruya Private Equity Inc. will join the company's board of directors.お知らせ • May 18MedMen Enterprises Inc. announced that it has received $10 million in fundingMedMen Enterprises Inc. (CNSX:MMEN) announced a non-brokered Private Placement of 31,250,000? units at a price of $0.32 per unit for gross proceeds of $10,000,000 on May 17, 2021. Each unit consists of one Class B subordinate voting share and one share purchase warrant. Each warrant permits the holder to purchase one Share for a period of three years from the date of issuance at an exercise price of $0.352 per share.お知らせ • May 13MedMen Enterprises Inc. announced delayed 10-Q filingOn 05/12/2021, MedMen Enterprises Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Mar 19MedMen Enterprises Inc. announced that it expects to receive CAD 8 million in fundingMedMen Enterprises Inc. (CNSX:MMEN) announced a non-brokered Private Placement of 20,000,000 units at a price of CAD 0.40 per unit for gross proceeds of CAD 8,000,000 on March 18, 2021. Each unit consists of one Class B subordinate voting share and one share purchase warrant. Each warrant permits the holder to purchase one Share for a period of three years from the date of issuance at an exercise price of CAD 0.50 per Share.お知らせ • Feb 11MedMen Enterprises Inc. announced delayed 10-Q filingOn 02/10/2021, MedMen Enterprises Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Feb 04MedMen Enterprises Inc. to Report Q2, 2021 Results on Feb 16, 2021MedMen Enterprises Inc. announced that they will report Q2, 2021 results on Feb 16, 2021お知らせ • Jan 05MedMen Relaunches MedMen RedMedMen announced the relaunch of its signature house brand, MedMen Red in all California and Nevada locations. The line, first introduced in November 2019, is the intersection of premium quality and value, providing customers with exceptional cannabis products at very compelling prices. Cultivated locally in each state through a meticulous growing process, which takes about 14 weeks from seed to sale, every product is carefully considered. Offering a full product suite, including flower ($38/3.5g, $65/7g), pre-rolls ($9/single, $38/7-pack), cartridges ($38/1g), disposable vapes ($25/0.3g), and edibles ($15/10-pack), the MedMen Red line curates high quality, accessible cannabis for all. Company's premium flower strains include White Runtz, a derivative of Leafly’s Strain of the Year 2020, as well as two strains, GMO Cookies and MAC, with over 30% cannabinoid content. The line of disposable vapes and cartridges include classic strains like Pineapple Express, Northern Lights and Maui Wowie, while succulent flavors of Dragon Fruit, Key Lime, Mango, Strawberry, and Pineapple comprise the gummy offering.お知らせ • Dec 30MedMen Enterprises Announces Board ChangesMedMen Enterprises reported that Tom Lynch has been elected as Chairman of the Board of Directors, effective immediately. Lynch currently serves as the interim Chief Executive Officer for MedMen and was elected to the Board of Directors in November. Ben Rose has resigned as Chairman of the Board of Directors and as a Board member.お知らせ • Dec 20+ 1 more updateMedmen Enterprises Inc. Announces Resignation of Benjamin Rose from the Board of DirectorsOn December 14, 2020, Benjamin Rose provided his resignation to the Board of Directors of MedMen Enterprises Inc., effective immediately.お知らせ • Dec 18MedMen Enterprises Inc. Announces Board ChangesMedMen Enterprises Inc. announced that Tom Lynch has been elected as Chairman of the Board of Directors, effective immediately. Lynch currently serves as the interim Chief Executive Officer for MedMen and was elected to the Board of Directors in November. Ben Rosehas resigned as Chairman of the Board of Directors and as a Board member.お知らせ • Dec 04Medmen Enterprises Inc. Names Tracy Mccourt to the New Role of Chief Revenue OfficerMedMen Enterprises Inc. named Tracy McCourt to the new role of Chief Revenue Officer. In this role, McCourt will report directly to the Chief Executive Officer and lead the omni-channel marketing strategy as well as the Company's buying, merchandising and business intelligence efforts. Most recently, McCourt led the strategy for the brand affinity team at Zappos, where she developed the brand marketing strategy to align business goals with merchandising strategy.お知らせ • Nov 25MedMen Enterprises Inc. to Report Q1, 2021 Results on Dec 07, 2020MedMen Enterprises Inc. announced that they will report Q1, 2021 results at 5:00 PM, Eastern Standard Time on Dec 07, 2020お知らせ • Nov 24MedMen Enterprises Inc. Announces Launch of Viola Within All California LocationsMedMen Enterprises Inc. announced the launch of Viola within all California locations. Founded in 2011 by NBA veteran and MedMen board member, Al Harrington, Viola is a premium cannabis company that focuses on increasing minority ownership, reinvesting in the community and creating opportunity through social equity. Launching with five potent strains; J1, Wedding Cake, Watermelon Zkittlez, Mother’s Milk and Mandarin OG – the offer spans the full spectrum from sativa to indica. The launch will also include Viola’s sativa Candy Haze pre-roll. See full descriptions, as promoted, below. Flower Descriptions: J1: J1 is an uplifting super sativa nothing short of a clear headed buzz. Enticing trichome encrusted buds, accompanied by a tantalizing sweet aroma known to leave user feeling unstoppable!; Wedding Cake: This delectable strain offers euphoric effects with its peppery and earthy flavor profile. Novice smokers beware this indica dominant hybrid may knock sweet tooth out; Watermelon Zkittlez: Large dense nugs with a flavor profile reminiscent of favorite fruit candy, Watermelon Zkittlez is the perfect midnight snack to fulfill sweet tooth cravings. This scrumptious combo may ease to an elevated state of relaxation; Mandarin OG: Boasting a unique flavor profile of skunky, spicy, pine-like and orange flavors this powerhouse strain is known to combine a heavy body high with extreme mental relaxation. The perfect strain to unwind with after a long day; Mother's Milk: Luscious trichome encrusted dense nugs coupled with an earthy flavor profile may allow for a functional dreamy high. This sativa dominant hybrid is perfect for an evening out or a day relaxing in; Sativa Pre-Roll Description; and Candy Haze: Bred from Candyland and Haze, Candy Haze stays true to its origins supplying uplifting and stimulating effects. The perfect day time smoke or mood boosting high to get creative juices flowing.お知らせ • Sep 25MedMen Enterprises Inc. to Report Q4, 2020 Results on Oct 15, 2020MedMen Enterprises Inc. announced that they will report Q4, 2020 results on Oct 15, 2020お知らせ • Sep 17MedMen Enterprises Inc. announced that it expects to receive $10 million in fundingMedMen Enterprises Inc. (CNSX:MMEN) announced that a private placement of unsecured convertible debenture facility for gross proceeds of $10,000,000 on September 16, 2020. The company will issue the convertible debentures in the transaction. The transaction included participation from from existing lenders and institutional investors. On the same date, the company closed initial tranche of $1,000,000 and issued investors a total of 3,293,413 warrants, each exercisable at $0.21 per share for a period of 24 months from the date of issuance. The subsequent tranches expected to be closed in the coming months, subject to certain conditions. The convertible debentures shall have a conversion price equal to the closing price on the trading day immediately prior to the closing date, a maturity date of 24 months from the date of issuance and will bear interest from the date of issuance at 7.5% per annum, payable semi-annually in cash. The debentures issued to the investors for the initial tranche have a conversion price of $0.1670 per Class B Subordinate Voting Share. Subject to certain conditions, the company has the right to call additional tranches, totaling $1,000,000 each, no later than 20 trading days following the issuance of each tranche, including the initial tranche, up to a maximum of $10,000,000 under all tranches. The investors have the right to at least four additional tranches, with any such subsequent tranche to be at least $1,000,000. The debentures shall provide for the automatic conversion into shares in the event that the shares trade at a volume weighted average trading price that is 50% above the conversion price on the Canadian Securities Exchange for 45 consecutive trading days.お知らせ • Aug 25+ 1 more updateMedMen Enterprises Inc. (CNSX:MMEN) agreed to acquire all of the Assets of LVMC, LLC for $10.1 million.MedMen Enterprises Inc. (CNSX:MMEN) agreed to acquire all of the Assets of LVMC, LLC for $10.1 million on October 9, 2018. MedMen Enterprises Inc. (CNSX:MMEN) completed the acquisition of all of the Assets of LVMC, LLC on October 9, 2018.株主還元MMNF.QUS PharmaceuticalsUS 市場7D0%4.9%1.0%1Y0%44.2%28.7%株主還元を見る業界別リターン: MMNF.Q過去 1 年間で44.2 % の収益を上げたUS Pharmaceuticals業界を下回りました。リターン対市場: MMNF.Qは、過去 1 年間で28.7 % のリターンを上げたUS市場を下回りました。価格変動Is MMNF.Q's price volatile compared to industry and market?MMNF.Q volatilityMMNF.Q Average Weekly Movement0%Pharmaceuticals Industry Average Movement10.1%Market Average Movement7.2%10% most volatile stocks in US Market16.4%10% least volatile stocks in US Market3.1%安定した株価: データは利用できません。時間の経過による変動: 過去 1 年間のMMNF.Qのボラティリティの変化を判断するには データが不十分です。会社概要設立従業員CEO（最高経営責任者ウェブサイトn/an/an/awww.medmen.comMedMen Enterprises Inc.は、その子会社とともに米国で大麻小売業を営んでいる。同社はMedMen RedとLuxLyteのブランド名で商品を提供している。2022年6月25日現在、カリフォルニア州、ネバダ州、イリノイ州、アリゾナ州、マサチューセッツ州で19店舗を運営している。MedMen Enterprises Inc.はカリフォルニア州ロサンゼルスを拠点としている。もっと見るMedMen Enterprises Inc. 基礎のまとめMedMen Enterprises の収益と売上を時価総額と比較するとどうか。MMNF.Q 基礎統計学時価総額US$1.59k収益（TTM）-US$143.31m売上高(TTM)US$120.12m0.0xP/Sレシオ0.0xPER（株価収益率MMNF.Q は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計MMNF.Q 損益計算書（TTM）収益US$120.12m売上原価US$63.44m売上総利益US$56.68mその他の費用US$199.99m収益-US$143.31m直近の収益報告Mar 25, 2023次回決算日該当なし一株当たり利益（EPS）0グロス・マージン0.00%純利益率0.00%有利子負債／自己資本比率0.0%MMNF.Q の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/04/03 11:14終値2026/04/01 00:00収益2023/03/25年間収益2022/06/25データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋MedMen Enterprises Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。9 アナリスト機関David McFadgenATB Cormark Historical (Cormark Securities)Matt BottomleyCanaccord GenuityPablo ZuanicCantor Fitzgerald & Co.6 その他のアナリストを表示
お知らせ • Apr 28+ 1 more updateMedMen Enterprises Inc. Announces Resignation of DirectorsMedMen Enterprises Inc. announced that it made an assignment into bankruptcy pursuant to Canadas Bankruptcy and Insolvency Act (the Bankruptcy Proceedings) on April 24, 2024 and B. Riley Farber Inc. was appointed as the Company's bankruptcy trustee (in such capacity, the Bankruptcy Trustee). The each of the Company's directors resigned effective immediately prior to the commencement of the Bankruptcy Proceedings.
お知らせ • Jan 25+ 1 more updateMedMen Enterprises Inc. Announces Management ChangesMedMen Enterprises Inc. announced that Ellen Deutsch Harrison has stepped down as board member effective January 19, 2024 and the board has appointed Richard Ormond as chief restructuring officer. Furthermore, Michael Serruya, executive chairman of the board, who has served on the Board since August 2021, has stepped down from the Board effective January 24, 2024.
お知らせ • Nov 18MedMen Enterprises Inc. announced delayed 10-Q filingOn 11/17/2023, MedMen Enterprises Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jul 06+ 2 more updatesMedMen Enterprises Inc. Appoints Ellen Deutsch to Board of DirectorsMedMen Enterprises Inc. announced the appointment of Ellen Deutsch to the Company’s Board of Directors, increasing the size of the Board of Directors to six. Deutsch brings deep operational, marketing, and financial experience and expertise in the cannabis and CPG industries, having most recently served as Senior Vice President of Market Development and Shared Services at Acreage Holdings. Before joining Acreage, Deutsch served as Executive Vice President/Chief Operating Officer at Stem Holdings, Inc, following two decades in the C-suite of Hain Celestial as its Senior Vice President/Chief Growth Officer among other leadership roles.
お知らせ • Jun 17MedMen Enterprises Inc. Announces CFO Changes, Effective June 29, 2023MedMen Enterprises Inc. announced the resignation of Ana Bowman as Chief Financial Officer, effective June 29, 2023. Bowman has served as CFO since 2022. MedMen has begun a formal search for a new CFO.
お知らせ • May 06MedMen Enterprises Inc. announced delayed 10-Q filingOn 05/05/2023, MedMen Enterprises Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Apr 28+ 1 more updateMedMen Enterprises Inc. Announces Resignation of DirectorsMedMen Enterprises Inc. announced that it made an assignment into bankruptcy pursuant to Canadas Bankruptcy and Insolvency Act (the Bankruptcy Proceedings) on April 24, 2024 and B. Riley Farber Inc. was appointed as the Company's bankruptcy trustee (in such capacity, the Bankruptcy Trustee). The each of the Company's directors resigned effective immediately prior to the commencement of the Bankruptcy Proceedings.
お知らせ • Jan 25+ 1 more updateMedMen Enterprises Inc. Announces Management ChangesMedMen Enterprises Inc. announced that Ellen Deutsch Harrison has stepped down as board member effective January 19, 2024 and the board has appointed Richard Ormond as chief restructuring officer. Furthermore, Michael Serruya, executive chairman of the board, who has served on the Board since August 2021, has stepped down from the Board effective January 24, 2024.
お知らせ • Nov 18MedMen Enterprises Inc. announced delayed 10-Q filingOn 11/17/2023, MedMen Enterprises Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jul 06+ 2 more updatesMedMen Enterprises Inc. Appoints Ellen Deutsch to Board of DirectorsMedMen Enterprises Inc. announced the appointment of Ellen Deutsch to the Company’s Board of Directors, increasing the size of the Board of Directors to six. Deutsch brings deep operational, marketing, and financial experience and expertise in the cannabis and CPG industries, having most recently served as Senior Vice President of Market Development and Shared Services at Acreage Holdings. Before joining Acreage, Deutsch served as Executive Vice President/Chief Operating Officer at Stem Holdings, Inc, following two decades in the C-suite of Hain Celestial as its Senior Vice President/Chief Growth Officer among other leadership roles.
お知らせ • Jun 17MedMen Enterprises Inc. Announces CFO Changes, Effective June 29, 2023MedMen Enterprises Inc. announced the resignation of Ana Bowman as Chief Financial Officer, effective June 29, 2023. Bowman has served as CFO since 2022. MedMen has begun a formal search for a new CFO.
お知らせ • May 06MedMen Enterprises Inc. announced delayed 10-Q filingOn 05/05/2023, MedMen Enterprises Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Nov 24Medmen Enterprises Inc. Prevails in Lawsuit Against Former CFO James ParkerMedMen Enterprises Inc. announced the company has prevailed in a high-profile lawsuit brought by former CFO James Parker. In 2019, Parker filed suit against MedMen, alleging wrongful termination, breach of contract and retaliation, seeking in excess of $20,000,000.00 in damages. MedMen has always maintained that the lawsuit and claims were baseless and without merit. The jury agreed, ruling in favor of MedMen on all claims and determining MedMen does not owe Parker any damages. MedMen also asserted affirmative claims against Parker. The jury found that Parker breached his contract, his fiduciary duty, his duty of loyalty, misappropriated trade secrets, and committed conversion, but that there was no harm/damage resulting from his misconduct.
お知らせ • Aug 19MedMen Enterprises Inc. announced that it expects to receive $100 million in funding from Serruya Private Equity Inc.MedMen Enterprises Inc. announced a private placement of 416,666,667 units at a price of $0.24 per unit for gross proceeds of $100,000,000 on August 17, 2021. Each unit will consist of one class B subordinated voting share and one quarter of one share purchase warrant. Each warrant will entitle the holder to purchase a common share at a price of $0.288 per share for a period of five years. The transaction will be led by Serruya Private Equity Inc and included participation from other investors. Pursuant to the transaction, Michael Serruya from Serruya Private Equity Inc. will join the company's board of directors.
お知らせ • May 18MedMen Enterprises Inc. announced that it has received $10 million in fundingMedMen Enterprises Inc. (CNSX:MMEN) announced a non-brokered Private Placement of 31,250,000? units at a price of $0.32 per unit for gross proceeds of $10,000,000 on May 17, 2021. Each unit consists of one Class B subordinate voting share and one share purchase warrant. Each warrant permits the holder to purchase one Share for a period of three years from the date of issuance at an exercise price of $0.352 per share.
お知らせ • May 13MedMen Enterprises Inc. announced delayed 10-Q filingOn 05/12/2021, MedMen Enterprises Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Mar 19MedMen Enterprises Inc. announced that it expects to receive CAD 8 million in fundingMedMen Enterprises Inc. (CNSX:MMEN) announced a non-brokered Private Placement of 20,000,000 units at a price of CAD 0.40 per unit for gross proceeds of CAD 8,000,000 on March 18, 2021. Each unit consists of one Class B subordinate voting share and one share purchase warrant. Each warrant permits the holder to purchase one Share for a period of three years from the date of issuance at an exercise price of CAD 0.50 per Share.
お知らせ • Feb 11MedMen Enterprises Inc. announced delayed 10-Q filingOn 02/10/2021, MedMen Enterprises Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Feb 04MedMen Enterprises Inc. to Report Q2, 2021 Results on Feb 16, 2021MedMen Enterprises Inc. announced that they will report Q2, 2021 results on Feb 16, 2021
お知らせ • Jan 05MedMen Relaunches MedMen RedMedMen announced the relaunch of its signature house brand, MedMen Red in all California and Nevada locations. The line, first introduced in November 2019, is the intersection of premium quality and value, providing customers with exceptional cannabis products at very compelling prices. Cultivated locally in each state through a meticulous growing process, which takes about 14 weeks from seed to sale, every product is carefully considered. Offering a full product suite, including flower ($38/3.5g, $65/7g), pre-rolls ($9/single, $38/7-pack), cartridges ($38/1g), disposable vapes ($25/0.3g), and edibles ($15/10-pack), the MedMen Red line curates high quality, accessible cannabis for all. Company's premium flower strains include White Runtz, a derivative of Leafly’s Strain of the Year 2020, as well as two strains, GMO Cookies and MAC, with over 30% cannabinoid content. The line of disposable vapes and cartridges include classic strains like Pineapple Express, Northern Lights and Maui Wowie, while succulent flavors of Dragon Fruit, Key Lime, Mango, Strawberry, and Pineapple comprise the gummy offering.
お知らせ • Dec 30MedMen Enterprises Announces Board ChangesMedMen Enterprises reported that Tom Lynch has been elected as Chairman of the Board of Directors, effective immediately. Lynch currently serves as the interim Chief Executive Officer for MedMen and was elected to the Board of Directors in November. Ben Rose has resigned as Chairman of the Board of Directors and as a Board member.
お知らせ • Dec 20+ 1 more updateMedmen Enterprises Inc. Announces Resignation of Benjamin Rose from the Board of DirectorsOn December 14, 2020, Benjamin Rose provided his resignation to the Board of Directors of MedMen Enterprises Inc., effective immediately.
お知らせ • Dec 18MedMen Enterprises Inc. Announces Board ChangesMedMen Enterprises Inc. announced that Tom Lynch has been elected as Chairman of the Board of Directors, effective immediately. Lynch currently serves as the interim Chief Executive Officer for MedMen and was elected to the Board of Directors in November. Ben Rosehas resigned as Chairman of the Board of Directors and as a Board member.
お知らせ • Dec 04Medmen Enterprises Inc. Names Tracy Mccourt to the New Role of Chief Revenue OfficerMedMen Enterprises Inc. named Tracy McCourt to the new role of Chief Revenue Officer. In this role, McCourt will report directly to the Chief Executive Officer and lead the omni-channel marketing strategy as well as the Company's buying, merchandising and business intelligence efforts. Most recently, McCourt led the strategy for the brand affinity team at Zappos, where she developed the brand marketing strategy to align business goals with merchandising strategy.
お知らせ • Nov 25MedMen Enterprises Inc. to Report Q1, 2021 Results on Dec 07, 2020MedMen Enterprises Inc. announced that they will report Q1, 2021 results at 5:00 PM, Eastern Standard Time on Dec 07, 2020
お知らせ • Nov 24MedMen Enterprises Inc. Announces Launch of Viola Within All California LocationsMedMen Enterprises Inc. announced the launch of Viola within all California locations. Founded in 2011 by NBA veteran and MedMen board member, Al Harrington, Viola is a premium cannabis company that focuses on increasing minority ownership, reinvesting in the community and creating opportunity through social equity. Launching with five potent strains; J1, Wedding Cake, Watermelon Zkittlez, Mother’s Milk and Mandarin OG – the offer spans the full spectrum from sativa to indica. The launch will also include Viola’s sativa Candy Haze pre-roll. See full descriptions, as promoted, below. Flower Descriptions: J1: J1 is an uplifting super sativa nothing short of a clear headed buzz. Enticing trichome encrusted buds, accompanied by a tantalizing sweet aroma known to leave user feeling unstoppable!; Wedding Cake: This delectable strain offers euphoric effects with its peppery and earthy flavor profile. Novice smokers beware this indica dominant hybrid may knock sweet tooth out; Watermelon Zkittlez: Large dense nugs with a flavor profile reminiscent of favorite fruit candy, Watermelon Zkittlez is the perfect midnight snack to fulfill sweet tooth cravings. This scrumptious combo may ease to an elevated state of relaxation; Mandarin OG: Boasting a unique flavor profile of skunky, spicy, pine-like and orange flavors this powerhouse strain is known to combine a heavy body high with extreme mental relaxation. The perfect strain to unwind with after a long day; Mother's Milk: Luscious trichome encrusted dense nugs coupled with an earthy flavor profile may allow for a functional dreamy high. This sativa dominant hybrid is perfect for an evening out or a day relaxing in; Sativa Pre-Roll Description; and Candy Haze: Bred from Candyland and Haze, Candy Haze stays true to its origins supplying uplifting and stimulating effects. The perfect day time smoke or mood boosting high to get creative juices flowing.
お知らせ • Sep 25MedMen Enterprises Inc. to Report Q4, 2020 Results on Oct 15, 2020MedMen Enterprises Inc. announced that they will report Q4, 2020 results on Oct 15, 2020
お知らせ • Sep 17MedMen Enterprises Inc. announced that it expects to receive $10 million in fundingMedMen Enterprises Inc. (CNSX:MMEN) announced that a private placement of unsecured convertible debenture facility for gross proceeds of $10,000,000 on September 16, 2020. The company will issue the convertible debentures in the transaction. The transaction included participation from from existing lenders and institutional investors. On the same date, the company closed initial tranche of $1,000,000 and issued investors a total of 3,293,413 warrants, each exercisable at $0.21 per share for a period of 24 months from the date of issuance. The subsequent tranches expected to be closed in the coming months, subject to certain conditions. The convertible debentures shall have a conversion price equal to the closing price on the trading day immediately prior to the closing date, a maturity date of 24 months from the date of issuance and will bear interest from the date of issuance at 7.5% per annum, payable semi-annually in cash. The debentures issued to the investors for the initial tranche have a conversion price of $0.1670 per Class B Subordinate Voting Share. Subject to certain conditions, the company has the right to call additional tranches, totaling $1,000,000 each, no later than 20 trading days following the issuance of each tranche, including the initial tranche, up to a maximum of $10,000,000 under all tranches. The investors have the right to at least four additional tranches, with any such subsequent tranche to be at least $1,000,000. The debentures shall provide for the automatic conversion into shares in the event that the shares trade at a volume weighted average trading price that is 50% above the conversion price on the Canadian Securities Exchange for 45 consecutive trading days.
お知らせ • Aug 25+ 1 more updateMedMen Enterprises Inc. (CNSX:MMEN) agreed to acquire all of the Assets of LVMC, LLC for $10.1 million.MedMen Enterprises Inc. (CNSX:MMEN) agreed to acquire all of the Assets of LVMC, LLC for $10.1 million on October 9, 2018. MedMen Enterprises Inc. (CNSX:MMEN) completed the acquisition of all of the Assets of LVMC, LLC on October 9, 2018.
